MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory ...

Small Molecule Drug Development Core Facility (SMDD Core) has the automation equipment, libraries, and experienced personnel to support a wide range of assay ...

The Global Small Molecule Innovator CDMO Market offers opportunities in outsourcing due to growing structural drug complexity and increased investments. Key areas include partnerships with emerging ...

Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

GSK said it is ending the development program for the small-molecule drug Belrestotug. The British pharmaceutical giant said Tuesday that the decision is based on a new interim analyses from phase 2 ...

The goal of a small-molecule drug discovery campaign is the development of chemical entities that fulfil the criteria of the target product profile for progression into clinical trials. This objective ...

The agreement includes an upfront payment, with potential future payments linked to development, regulatory, and commercial ...

Eli Lilly and Co. is collaborating with Boston-based Superluminal Medicines to use artificial intelligence to discover small-molecule drugs for cardiometabolic disease and obesity in an agreement ...

Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...

The Inflation Reduction Act represents a landmark shift in U.S. drug pricing regulation, introducing direct federal negotiation of drug prices for the first time. Notably, the IRA imposes earlier ...